🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The piece on "Breakthrough Device Could Ease Deep Depression" bit.ly/3C9WPz3 features a range of Soterix Medical solutions: 1X1 tES, MXN HD-tES, MR compatible solution, and home headgear bit.ly/3xZZDMH #tDCS #HDtDCS #HDtES #neuromodulation #brainstim

Soterix Medical Announces award of Fast Track NIH grant to develop a Parcel-Guided software to improve efficacy of rTMS treatment for #depression prn.to/3TieQ3V Learn about Navigated rTMS for Depression:bit.ly/3g5vjKA & navigation: bit.ly/3T15jOZ

Introducing the MXN-10 REMOTE system for home High Definition-tES. Uniquely designed to provide unmatched control and reliability in conducting trials in deployed environments- without compromising dose precision and safety bit.ly/3jX20Mx #brainstim #HDtDCS #HDtES

Are are interested in creating innovative solutions for the future #healthcare? Apply for the City College’s Master's in Translational Medicine (MTM). Application Deadline has been extended to Friday, May 26, 2023. #innovation #medicaltechnology #translationalmedicine

Soterix Medical Announces Patient Recruitment for Parcel-Guided rTMS Depression Trial prn.to/42jpc8O Trial includes individuals who received #rTMS but did not adequately respond. Interested candidates can contact us directly. #depression #trial

Soterix Medical is pleased to announce that our home-based #tDCS platform will be used in the RECOVER-NEURO portion of the NIH RECOVER initiative, which will examine interventions for cognitive dysfunction related to long COVID. #NIHRECOVER

Soterix Medical announces Phase-2 trial to test at-home tDCS paired with cognitive training as a therapeutic option for long COVID prn.to/3QYWU0u The trial will be administered by NYU Langone Health as part of the NIH RECOVER initiative. #NIHRECOVER

📣New publication from the Soterix Medical R&D team on optimized #HDtDCS in patients with skull defects and plates. Results indicated optimized montages achieved greater stim intensity regardless of defect. Size/type of defect did affect current flow. bit.ly/3rVy73l

Big effort finally paid off - we joined Soterix Medical tES vision by adding EEG to it - to make an amazing MxN-GO EEG system! Mobile, wearable, light - what a powerful tool! Drop by Soterix booth (#416) mbt #SfN23

We were formed to develop HD-tES as the first transcranial system capable of brain targeting with weak electrical stim in 2008. On our 15th yr of existence,we are ecstatic to introduce our next revolution-a fully wireless tES+EEG soln.Not to be missed if you are at #SfN23

The "MXN-GO EEG" is the result of our partnership with mbraintrain,a company that has equally pushed the limits of what's possible in their domain of expertise (mobile EEG),a company that is equally committed to bringing innovation in neuroscience mbt @ Booth 416 #SfN23

Why is MXN-G0 EEG ground breaking?It combines the stimulation tolerability,reproducibility,performance,& know-how that we have accumulated over 15 yrs with the unmatched mobile #EEG collection expertise of mbt in one form factor tinyurl.com/bd3jm3m2 #HDtES #HDtDCS

We're excited for day 2 at #CNS2024 in Toronto! Swing by Booth 104 to check out our newly launched MxN-GO EEG system, featuring our groundbreaking wireless #HDtES + #EEG technology. Dive into cutting-edge research with 33 channels of stimulation and 32 channels of EEG.

The MxN-GO EEG is finally here. From its first unveil at #SfN23 to now formally offering to the community. The GO soln combines our innovations in #HDtES spanning >16 yrs with the de facto best mobile EEG system in the world-into one product. Thanks to mbt Now Lets GO!

MxN-GO EEG is now formally available! shorturl.at/dAEHK More about the first fully wire-free combined HD-tES and EEG solution: shorturl.at/luEG3 Interested researchers can contact us directly #HDtDCS #HDtES #EEG #neuroscience #neuromodulation #brainstim mbt

Exciting news! Soterix Medical has received FDA 510(k) clearance for our MEGA-IOM Intraoperative Neuromonitoring system prn.to/4fdZzwT. MEGA-IOM offers unmatched integrated control of central and peripheral nervous systems, reducing post-operative risk. #IOM #IONM

We continue to remain committed to develop+ commercialize solutions. The MEGA-IOM reflects our fourth 510(k) clearance. The system is on display at the ASET meeting this week. If you are attending, pay special attention to the rich software interface. ASET - The Neurodiagnostic Society #ASET2024

We’re excited to see everyone at the 2024 NYC Neuromodulation Conference! Visit Booth #14 to speak with our team about our neuromodulation and neuromonitoring technologies! #NYCN2024

Soterix Medical workshop on the latest technology updates in neuromodulation and neuromonitorong at the 2024 NYC Neuromodulation Conference. #NYCN2024